Skip to main content
. 2017 Mar 15;6(4):778–787. doi: 10.1002/cam4.996

Figure 3.

Figure 3

miR‐126 expression is decreased with CLL progression. (A) qRT‐PCR analysis of EGFL7 in normal donor B cells (n = 6), treatment‐naive CLL patients (n = 14), and previously treated CLL patients (n = 15). (B) qRT‐PCR analysis of pri‐miR‐126 in normal donor B cells (n = 4), treatment‐naive CLL patients (n = 12), and previously treated CLL patients (n = 14). (C) qRT‐PCR analysis of mature miR‐126 in normal donor B cells (n = 6), treatment‐naive CLL patients (n = 15), and previously treated CLL patients (n = 15). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001.